Safety and clinical outcomes of endovascular ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke.
Author(s) :
Mujanovic, A. [Auteur]
Strbian, D. [Auteur]
Demeestere, J. [Auteur]
Marto, J. P. [Auteur]
Puetz, V. [Auteur]
Nogueira, R. G. [Auteur]
Abdalkader, M. [Auteur]
Nagel, S. [Auteur]
Raymond, J. [Auteur]
Ribo, M. [Auteur]
Michel, P. [Auteur]
Yoshimura, S. [Auteur]
Zaidat, O. O. [Auteur]
Winzer, S. [Auteur]
Ortega-Gutierrez, S. [Auteur]
Sheth, S. A. [Auteur]
Siegler, J. E. [Auteur]
Dusart, A. [Auteur]
Haussen, D. C. [Auteur]
Henon, Hilde [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Serrallach, B. L. [Auteur]
Mohammaden, M. H. [Auteur]
Möhlenbruch, M. A. [Auteur]
Olive-Gadea, M. [Auteur]
Puri, A. S. [Auteur]
Sakai, N. [Auteur]
Klein, P. [Auteur]
Tomppo, L. [Auteur]
Caparros, F. [Auteur]
Ramos, J. N. [Auteur]
Jumaa, M. [Auteur]
Zaidi, S. [Auteur]
Dobrocky, T. [Auteur]
Martinez-Majander, N. [Auteur]
Nannoni, S. [Auteur]
Bellante, F. [Auteur]
Rodriguez-Calienes, A. [Auteur]
Salazar-Marioni, S. [Auteur]
Virtanen, P. [Auteur]
Kaiser, D. P. [Auteur]
Ventura, R. [Auteur]
Jesser, J. [Auteur]
Castonguay, A. C. [Auteur]
Qureshi, M. M. [Auteur]
Masoud, H. E. [Auteur]
Galecio-Castillo, M. [Auteur]
Requena, M. [Auteur]
Lauha, R. [Auteur]
Hu, W. [Auteur]
Lin, E. [Auteur]
Miao, Z. [Auteur]
Roy, D. [Auteur]
Yamagami, H. [Auteur]
Seiffge, D. J. [Auteur]
Strambo, D. [Auteur]
Ringleb, P. A. [Auteur]
Lemmens, R. [Auteur]
Fischer, U. [Auteur]
Nguyen, N Thank [Auteur]
Boston University [Boston] [BU]
Kaesmacher, Johannes [Auteur]
Bern University Hospital [Berne] [Inselspital]
Strbian, D. [Auteur]
Demeestere, J. [Auteur]
Marto, J. P. [Auteur]
Puetz, V. [Auteur]
Nogueira, R. G. [Auteur]
Abdalkader, M. [Auteur]
Nagel, S. [Auteur]
Raymond, J. [Auteur]
Ribo, M. [Auteur]
Michel, P. [Auteur]
Yoshimura, S. [Auteur]
Zaidat, O. O. [Auteur]
Winzer, S. [Auteur]
Ortega-Gutierrez, S. [Auteur]
Sheth, S. A. [Auteur]
Siegler, J. E. [Auteur]
Dusart, A. [Auteur]
Haussen, D. C. [Auteur]
Henon, Hilde [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Serrallach, B. L. [Auteur]
Mohammaden, M. H. [Auteur]
Möhlenbruch, M. A. [Auteur]
Olive-Gadea, M. [Auteur]
Puri, A. S. [Auteur]
Sakai, N. [Auteur]
Klein, P. [Auteur]
Tomppo, L. [Auteur]
Caparros, F. [Auteur]
Ramos, J. N. [Auteur]
Jumaa, M. [Auteur]
Zaidi, S. [Auteur]
Dobrocky, T. [Auteur]
Martinez-Majander, N. [Auteur]
Nannoni, S. [Auteur]
Bellante, F. [Auteur]
Rodriguez-Calienes, A. [Auteur]
Salazar-Marioni, S. [Auteur]
Virtanen, P. [Auteur]
Kaiser, D. P. [Auteur]
Ventura, R. [Auteur]
Jesser, J. [Auteur]
Castonguay, A. C. [Auteur]
Qureshi, M. M. [Auteur]
Masoud, H. E. [Auteur]
Galecio-Castillo, M. [Auteur]
Requena, M. [Auteur]
Lauha, R. [Auteur]
Hu, W. [Auteur]
Lin, E. [Auteur]
Miao, Z. [Auteur]
Roy, D. [Auteur]
Yamagami, H. [Auteur]
Seiffge, D. J. [Auteur]
Strambo, D. [Auteur]
Ringleb, P. A. [Auteur]
Lemmens, R. [Auteur]
Fischer, U. [Auteur]
Nguyen, N Thank [Auteur]
Boston University [Boston] [BU]
Kaesmacher, Johannes [Auteur]
Bern University Hospital [Berne] [Inselspital]
Journal title :
European Stroke Journal
Abbreviated title :
Eur Stroke J
Pages :
23969873241249406
Publisher :
SAGE Journals
Publication date :
2024-06-01
ISSN :
2396-9881
English keyword(s) :
Endovascular therapy
mechanical thrombectomy
best medical treatment
large ischemic core
extended time-window
mechanical thrombectomy
best medical treatment
large ischemic core
extended time-window
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Introduction:
The benefit of endovascular therapy (EVT) among stroke patients with large ischemic core (ASPECTS 0–5) in the extended time window outside of trial settings remains unclear. We analyzed the effect of EVT ...
Show more >Introduction: The benefit of endovascular therapy (EVT) among stroke patients with large ischemic core (ASPECTS 0–5) in the extended time window outside of trial settings remains unclear. We analyzed the effect of EVT among these stroke patients in real-world settings. Patients and methods: The CT for Late Endovascular Reperfusion (CLEAR) study recruited patients from 66 centers in 10 countries between 01/2014 and 05/2022. The extended time-window was defined as 6–24 h from last-seen-well to treatment. The primary outcome was shift of the 3-month modified Rankin scale (mRS) score. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and mortality. Outcomes were analyzed with ordinal and logistic regressions. Results: Among 5098 screened patients, 2451 were included in the analysis (median age 73, 55% women). Of patients with ASPECTS 0–5 (n = 310), receiving EVT (n = 209/310) was associated with lower 3-month mRS when compared to medical management (median 4 IQR 3–6 vs 6 IQR 4–6; aOR 0.4, 95% CI 0.2–0.7). Patients undergoing EVT had higher sICH (11.2% vs 4.0%; aOR 4.1, 95% CI 1.2–18.8) and lower mortality (31.6% vs 58.4%, aOR 0.4; 95% CI 0.2–0.9) compared to medically managed patients. The relative benefit of EVT was comparable between patients with ASPECTS 0 and 5 and 6–10 in the extended time window (interaction aOR 0.9; 95% CI 0.5–1.7). Conclusion: In the extended time window, patients with ASPECTS 0–5 may have preserved relative treatment benefit of EVT compared to patients with ASPECTS 6–10. These findings are in line with recent trials showing benefit of EVT among real-world patients with large ischemic core in the extended time window.Show less >
Show more >Introduction: The benefit of endovascular therapy (EVT) among stroke patients with large ischemic core (ASPECTS 0–5) in the extended time window outside of trial settings remains unclear. We analyzed the effect of EVT among these stroke patients in real-world settings. Patients and methods: The CT for Late Endovascular Reperfusion (CLEAR) study recruited patients from 66 centers in 10 countries between 01/2014 and 05/2022. The extended time-window was defined as 6–24 h from last-seen-well to treatment. The primary outcome was shift of the 3-month modified Rankin scale (mRS) score. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and mortality. Outcomes were analyzed with ordinal and logistic regressions. Results: Among 5098 screened patients, 2451 were included in the analysis (median age 73, 55% women). Of patients with ASPECTS 0–5 (n = 310), receiving EVT (n = 209/310) was associated with lower 3-month mRS when compared to medical management (median 4 IQR 3–6 vs 6 IQR 4–6; aOR 0.4, 95% CI 0.2–0.7). Patients undergoing EVT had higher sICH (11.2% vs 4.0%; aOR 4.1, 95% CI 1.2–18.8) and lower mortality (31.6% vs 58.4%, aOR 0.4; 95% CI 0.2–0.9) compared to medically managed patients. The relative benefit of EVT was comparable between patients with ASPECTS 0 and 5 and 6–10 in the extended time window (interaction aOR 0.9; 95% CI 0.5–1.7). Conclusion: In the extended time window, patients with ASPECTS 0–5 may have preserved relative treatment benefit of EVT compared to patients with ASPECTS 6–10. These findings are in line with recent trials showing benefit of EVT among real-world patients with large ischemic core in the extended time window.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-06-22T21:11:40Z
2024-10-30T10:14:28Z
2024-10-30T10:14:28Z
Files
- mujanovic-et-al-2024-safety-and-clinical-outcomes-of-endovascular-therapy-versus-medical-management-in-late.pdf
- Non spécifié
- Restricted access
- Access the document